SRPT - Sarepta Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$25.14
DETAILS
HIGH:
$35.00
LOW:
$14.00
MEDIAN:
$25.00
CONSENSUS:
$25.14
UPSIDE:
49.64%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Dalio | 134,277 | $2.9M | 0.0% | -146,291 | DECREASED |
| Cooperman | 126,800 | $2.8M | 0.0% | +49,700 | INCREASED |
| Greenblatt | 47,552 | $1.0M | 0.0% | -174,178 | DECREASED |
| Wood | 31,000 | $674,560 | 0.0% | -176,513 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-03-11 | Estepan Ian Michael | officer: Chief Operating Officer | F-InKind | 1,097 | $17.03 | $19K |
| 2026-03-11 | Wong Ryan Ho-Yan | officer: Chief Financial Officer | F-InKind | 256 | $17.03 | $4K |
| 2026-03-11 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | F-InKind | 948 | $17.03 | $16K |
| 2026-03-12 | Mayo Stephen | director | SELL | 7,239 | $17.02 | $123K |
| 2026-03-11 | Rothfuss Cristin | officer: EVP, General Counsel | F-InKind | 974 | $17.03 | $17K |
| 2026-03-09 | Estepan Ian Michael | officer: Chief Operating Officer | F-InKind | 583 | $16.95 | $10K |
| 2026-03-09 | Wong Ryan Ho-Yan | officer: Chief Financial Officer | F-InKind | 162 | $16.95 | $3K |
| 2026-03-09 | Wong Ryan Ho-Yan | officer: Chief Financial Officer | F-InKind | 113 | $16.95 | $2K |
| 2026-03-09 | Rothfuss Cristin | officer: EVP, General Counsel | F-InKind | 484 | $16.95 | $8K |
| 2026-03-09 | Rothfuss Cristin | officer: EVP, General Counsel | F-InKind | 346 | $16.95 | $6K |
| 2026-03-09 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | F-InKind | 504 | $16.95 | $9K |
| 2026-03-09 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | F-InKind | 895 | $16.95 | $15K |
| 2026-03-09 | Estepan Ian Michael | officer: Chief Operating Officer | F-InKind | 1,036 | $16.95 | $18K |
| 2026-03-01 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | M-Exempt | 8,125 | -- | -- |
| 2026-03-01 | Estepan Ian Michael | officer: Chief Operating Officer | M-Exempt | 8,125 | -- | -- |
| 2026-03-02 | Rothfuss Cristin | officer: EVP, General Counsel | F-InKind | 408 | $16.20 | $7K |
| 2026-03-02 | Wong Ryan Ho-Yan | officer: Chief Financial Officer | F-InKind | 450 | $16.20 | $7K |
| 2026-03-02 | Estepan Ian Michael | officer: Chief Operating Officer | F-InKind | 3,301 | $16.20 | $53K |
| 2026-03-02 | Estepan Ian Michael | officer: Chief Operating Officer | F-InKind | 875 | $16.20 | $14K |
| 2026-03-02 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | F-InKind | 3,718 | $16.20 | $60K |
| 2026-03-02 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | F-InKind | 767 | $16.20 | $12K |
| 2026-02-26 | Estepan Ian Michael | officer: Chief Operating Officer | M-Exempt | 5,381 | $13.71 | $74K |
| 2026-02-26 | Estepan Ian Michael | officer: Chief Operating Officer | M-Exempt | 2,069 | $13.71 | $28K |
| 2026-02-25 | Rodino-Klapac Louise | officer: President, R&D and Tech Ops | A-Award | 1,875 | -- | -- |
| 2026-02-25 | Estepan Ian Michael | officer: Chief Operating Officer | A-Award | 1,875 | -- | -- |